Results 11 to 20 of about 8,750,628 (402)

Human Papillomavirus Vaccines [PDF]

The Journal of Infectious Diseases, 2021
Abstract Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so without specific induction of mucosal immunity.
Lauri E, Markowitz, John T, Schiller
openaire   +2 more sources

Cell‐free human papillomavirus DNA kinetics after surgery for human papillomavirus–associated oropharyngeal cancer

Cancer, 2022
New ultrasensitive methods for detecting residual disease after surgery are needed in human papillomavirus–associated oropharyngeal squamous cell carcinoma (HPV+OPSCC).
Connor J O'Boyle, G. Siravegna, Shohreh Varmeh, Natalia Queenan, Alexa G Michel, Kim Chang Sing Pang, J. Stein, J. Thierauf, P. Sadow, W. Faquin, W. Wang, D. Deschler, K. Emerick, M. Varvares, Jong C Park, J. Clark, A. Chan, P. Busse, R. Corcoran, L. Wirth, D. Lin, A. Iafrate, J. Richmon, D. Faden   +23 more
semanticscholar   +1 more source

Human papillomavirus vaccines [PDF]

Canadian Medical Association Journal, 2017
Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70 ...
Shainoor J, Ismail, Shelley L, Deeks
openaire   +2 more sources

Persistent Human Papillomavirus Infection

Viruses, 2021
Simple Summary The success of HPV as an infectious agent lies not within its ability to cause disease, but rather in the adeptness of the virus to establish long-term persistent infection.
Ashley N. Della Fera, Alix Warburton, Tami L. Coursey, Simran Khurana, A. McBride   +4 more
semanticscholar   +1 more source

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review

Frontiers in Oncology, 2021
Human papillomavirus (HPV) has been the leading cause of cervical cancer for over 25 years. Approximately 5.5–11% of all cervical cancers are reported to be HPV-negative, which can be attributed to truly negative and false-negative results. The truly HPV-
Biyuan Xing, Jianfeng Guo, Yuhan Sheng, Gang Wu, Yingchao Zhao   +4 more
semanticscholar   +1 more source

Human papillomavirus-independent cervical cancer

International Journal of Gynecological Cancer, 2021
Cervical cancer is the fourth most frequent cancer in women worldwide, representing nearly 8% of all female cancer deaths every year. The majority of cases of cervical cancer are caused by human papillomavirus (HPV); however, up to 5% of tumors are not ...
Andreina Fernandes, David Viveros-Carreño, Jorge Hoegl, M. Ávila, R. Pareja   +4 more
semanticscholar   +1 more source

Effects of a Human Papilloma Virus (HPV) Prevention Education among Girls in 6 Grade Elementary School, South Korea

SAGE Open, 2023
Studies on human papillomavirus (HPV) prevention education and its educational effects for elementary school students are necessary. This study aimed to examine the effects of human papillomavirus (HPV) prevention education on knowledge about cervical ...
Jeon Hee Kim, Soonyoung Park, Youngmi Cho, Sohyune Sok   +3 more
doaj   +1 more source

HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis [PDF]

, 2009
Penile verrucous carcinoma is a rare disease and little is known of its aetiology or pathogenesis. In this study we examined cell-cycle proteins expression and correlation with human papillomavirus infection in a series of 15 pure penile verrucous ...
A Ouban, AL Cubilla, AL Cubilla, AL Cubilla, AL Cubilla, AL Cubilla, AL Seixas, AS Masih, AS Narayana, B Kleter, C Dianzani, C Missero, Catherine Corbishley, CB Bunker, CL Haycox, Daniel M Berney, David M Prowse, DE Johnson, DM Prowse, E Ferreux, EF Velazquez, Elena Ktori, Elzbieta Stankiewicz, FT Kraus, GD Higgins, IB Roninson, Jack Cuzick, JC Noel, JR Nevins, KH Cuesta, KW Chan, KY Lam, KY Lam, L Gregoire, Laurence Ambroisine, LC Cubilla, LH Sobin, LL Villa, LV Ackerman, M Gualco, M Senba, M Serrano, M Wong, MA Rubin, MR Cupp, MT Kiyabu, Nicholas Watkin, PA Adegboyega, PA Hall, PH McKee, S Pilotti, Sakunthala C Kudahetti, SL Harris, T Sano, TH Cheung, VA Tron, VA Varma, Xiaoxi Zhang, Y Koyamatsu   +58 more
core   +1 more source

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer. [PDF]

, 2017
Albendazole is an anti-helminthic drug that has been shown to exhibit anti-cancer properties, however its activity in head and neck squamous cell cancer (HNSCC) was unknown.
Barrett, John W, Black, Morgan, Boutros, Paul C, Datti, Alessandro, Fung, Kevin, Ghasemi, Farhad, Le, Carson Cao Son Huu, Leong, Hon Sing, Lowerison, Matthew R, MacNeil, Danielle, Mymryk, Joe S, Nichols, Anthony C, Palma, David A, Pinto, Nicole, Ruicci, Kara M, Vizeacoumar, Frederick, Winquist, Eric, Yoo, John   +17 more
core   +1 more source

Human Papillomavirus

Microbiology Spectrum, 2016
ABSTRACT Individuals with inherited immunodeficiencies, autoimmune disorders, organ or bone marrow transplantation, or infection with human immunodeficiency virus (HIV) are at increased risk of infection with both low-risk and high-risk human papillomavirus (HPV) types.
Eileen M, Burd, Christina L, Dean
openaire   +2 more sources